In systemic lupus erythematosus, chronic spontaneous urticaria did not raise SLEDAI scores, but cylindruria, mucosal ulcers, ...
MedPage Today on MSN
Study: Keep Hydroxychloroquine Doses High in Lupus
Hydroxychloroquine (HCQ) doses of at least 400 mg/day provided better symptom relief for Taiwanese people with systemic lupus ...
A new study finds that experiences of discrimination are associated with worse patient-reported lupus-related symptoms and depressive symptoms among people with systemic lupus erythematosus (SLE).
Background Cognitive impairment (CI) is one of the most common manifestations of neuropsychiatric systemic lupus ...
Cambridge: AstraZeneca has announced that Saphnelo (anifrolumab) has been approved in the European Union (EU) for ...
ICP-488 is an oral, potent, and selective TYK2 allosteric inhibitor. By binding to the JH2 domain, ICP-488 blocks the signal transduction of IL-23, IL-12, type 1 IFN, and other inflammatory cytokines, ...
AN understanding of the interrelations of pregnancy and systemic lupus erythematosus is of considerable clinical importance, particularly since the disease occurs most frequently in women during the ...
Systemic lupus erythematosus (SLE) is an autoantibody-mediated systemic autoimmune disease, predominantly affecting young females. Pregnancy is increasingly common in the setting of SLE, as survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback